A multicenter, randomized, double-blind, placebo-controlled study of the effect of ezetimibe plus simvastatin compared with simvastatin alone on flow-mediated brachial artery vasoactivity in subjects with primary hypercholesterolemia (The EFFECTS trial)

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled study of the effect of ezetimibe plus simvastatin compared with simvastatin alone on flow-mediated brachial artery vasoactivity in subjects with primary hypercholesterolemia (The EFFECTS trial)

Discontinued
Phase of Trial: Phase III

Latest Information Update: 15 May 2017

At a glance

  • Drugs Ezetimibe; Simvastatin
  • Indications Hypercholesterolaemia
  • Focus Pharmacodynamics
  • Acronyms EFFECTS
  • Sponsors Schering-Plough
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top